Dan Gibson, Ph.D
Dan Gibson is the CTO of Codex. He oversees Codex’s world-class R&D team and sets the technical vision for the company.
Dan is the inventor of the Gibson Assembly® method, which has over 4,000 citations in scientific literature, and is regarded as a luminary in the field of synthetic biology. He and his team are consistently pioneering new ways to advance the field of synthetic biology and pushing boundaries in the disciplines of personalized medicine, antibody therapy development, agriculture and industrial materials.
Dan and his team formed the foundational technology that drives the BioXp 3200TM and the Digital to Biologic Converter (DBC) and continue to develop new, cutting edge tools for whole genome design, synthesis and assembly, and activation. To learn more about the work of Dan’s team and the DBC view his 2018 Ted talk.
Prior to Codex, Dan was Vice President of DNA Technology at Synthetic Genomics where he spearheaded efforts to develop a rapid approach for producing viral genes used in pandemic vaccine production in 2013, and he led the team that developed the first synthesized minimal cell in the world in 2016. Prior to Synthetic Genomics Dan spent more than six years at the J. Craig Ventner Institute where he co-led the team that constructed the first synthetic bacterial genome in 2008 and the first synthetic cell in 2010.
Dr. Gibson earned his Ph.D. in Molecular Biology from the University of Southern California. Before earning his Ph.D., he earned his Bachelor’s degree in Biological Sciences from the State University of New York at Buffalo.